Abstract
Interleukin 1 (IL1) is a primary regulator of inflammatory and immune responses. Via its type I receptor it activates specific protein kinases, including the NF kappa B inducing kinase (NIK) and three distinct mitogen-activated protein (MAP) kinase cascades. These modulate a number of transcription factors including NF kappa B, AP1 and CREB each of which regulate a plethora of immediate early genes central to the inflammatory response. Phase I clinical trials of the soluble type I receptor and IRAP indicate that these have potential anti-inflammatory effects.
MeSH terms
-
Adaptor Protein Complex 1
-
Adaptor Protein Complex alpha Subunits
-
Adaptor Proteins, Vesicular Transport
-
Animals
-
CREB-Binding Protein
-
Calcium-Calmodulin-Dependent Protein Kinases / biosynthesis*
-
Enzyme Induction
-
Genes, Immediate-Early
-
Inflammation / drug therapy
-
Interleukin 1 Receptor Antagonist Protein
-
Interleukin-1 / physiology*
-
Membrane Proteins / biosynthesis
-
NF-kappa B / biosynthesis*
-
Nuclear Proteins / biosynthesis
-
Receptors, Interleukin-1 / antagonists & inhibitors
-
Receptors, Interleukin-1 / physiology*
-
Recombinant Proteins / therapeutic use
-
Sialoglycoproteins / therapeutic use
-
Trans-Activators / biosynthesis
Substances
-
Adaptor Protein Complex 1
-
Adaptor Protein Complex alpha Subunits
-
Adaptor Proteins, Vesicular Transport
-
Interleukin 1 Receptor Antagonist Protein
-
Interleukin-1
-
Membrane Proteins
-
NF-kappa B
-
Nuclear Proteins
-
Receptors, Interleukin-1
-
Recombinant Proteins
-
Sialoglycoproteins
-
Trans-Activators
-
CREB-Binding Protein
-
Calcium-Calmodulin-Dependent Protein Kinases